Dexamethasone sodium phosphate for encapsulation into autoerythrocytes

DRUG2 trials

Sponsors

Quince Therapeutics S.p.A.

Conditions

Ataxia TelangiectasiaAtaxia Telangiectasia (A-T)

Phase 3

A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Neurological Effects of EryDex on subjects with Ataxia-Telangiectasia.

CompletedCTIS2023-509077-23-00

Quince Therapeutics S.p.A.Ataxia Telangiectasia

Start: 2024-06-03End: 2025-12-17Target: 67Updated: 2026-01-14

An Open-Label Extension Study of EryDex in Patients with Ataxia-Telangiectasia Following Participation in Study IEDAT-04-2022 (NEAT)

RecruitingCTIS2024-513618-37-00

Quince Therapeutics S.p.A.Ataxia Telangiectasia (A-T)

Start: 2024-12-23Target: 70Updated: 2026-01-07